|
C11ORF82 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.642000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.006600E-01 |
| Normal-vs-Stage2 |
4.120200E-02 |
| Normal-vs-Stage3 |
7.184600E-01 |
| Normal-vs-Stage4 |
6.921800E-01 |
| Stage1-vs-Stage2 |
3.98700000000529E-05 |
| Stage1-vs-Stage3 |
8.080800E-01 |
| Stage1-vs-Stage4 |
7.759400E-01 |
| Stage2-vs-Stage3 |
1.971240E-04 |
| Stage2-vs-Stage4 |
7.255400E-03 |
| Stage3-vs-Stage4 |
8.962400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.021200E-01 |
| Normal-vs-AfricanAmerican |
5.852200E-01 |
| Normal-vs-Asian |
4.980400E-01 |
| Caucasian-vs-AfricanAmerican |
1.831560E-01 |
| Caucasian-vs-Asian |
6.058200E-01 |
| AfricanAmerican-vs-Asian |
1.727170E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.826600E-01 |
| Normal-vs-Female |
9.582400E-01 |
| Male-vs-Female |
9.579400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.434400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.704200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.064000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.668400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.556300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.271000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.615380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.755800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.180100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.674200E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.095700E-02 |
| Classical-VS-Follicular |
2.57682764015499E-12 |
| Classical-VS-Other |
9.915900E-03 |
| Classical-VS-Normal |
5.213600E-01 |
| Tall-VS-Follicular |
8.0415000003331E-07 |
| Tall-VS-Other |
3.633000E-04 |
| Tall-VS-Normal |
3.754200E-02 |
| Follicular-VS-Other |
9.367600E-01 |
| Follicular-VS-Normal |
1.704370E-02 |
| Other-VS-Normal |
7.763600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.058400E-01 |
| Normal-vs-N1 |
9.456800E-01 |
| N0-vs-N1 |
3.734200E-01 |
|
|
